3-カルバムイミドイルアミノ-4-メチル安息香酸エチル硝酸塩
3-カルバムイミドイルアミノ-4-メチル安息香酸エチル硝酸塩 物理性質
- 融点 :
- 197.0 to 201.0 °C
- 貯蔵温度 :
- Sealed in dry,Room Temperature
- 外見 :
- powder to crystal
- 色:
- White to Almost white
3-カルバムイミドイルアミノ-4-メチル安息香酸エチル硝酸塩 価格
もっと(6)
| メーカー |
製品番号 |
製品説明 |
CAS番号 |
包装 |
価格 |
更新時間 |
購入 |
|
富士フイルム和光純薬株式会社(wako)
|
W01COBQK-4255 |
3-[(アミノイミノメチル)アミノ]-4-メチル安息香酸エチル一硝酸エステル
3-[(Aminoiminomethyl)amino]-4-methylbenzoic acid ethyl ester mononitrate |
641569-96-2 |
1g |
￥10000 |
2024-03-01 |
購入 |
|
富士フイルム和光純薬株式会社(wako)
|
W01COBQK-4255 |
3-[(アミノイミノメチル)アミノ]-4-メチル安息香酸エチル一硝酸エステル
3-[(Aminoiminomethyl)amino]-4-methylbenzoic acid ethyl ester mononitrate |
641569-96-2 |
250mg |
￥28800 |
2023-06-01 |
購入 |
|
富士フイルム和光純薬株式会社(wako)
|
W01COBQK-4255 |
3-[(Aminoiminomethyl)amino]-4-methylbenzoic acid ethyl ester mononitrate |
641569-96-2 |
10g |
￥309600 |
2023-06-01 |
購入 |
|
東京化成工業
|
E1079 |
3-カルバムイミドイルアミノ-4-メチル安息香酸エチル硝酸塩 >97.0%(HPLC)(T)
Ethyl 3-Carbamimidoylamino-4-methylbenzoate Nitrate
>97.0%(HPLC)(T) |
641569-96-2 |
1g |
￥13500 |
2024-03-01 |
購入 |
|
東京化成工業
|
E1079 |
3-カルバムイミドイルアミノ-4-メチル安息香酸エチル硝酸塩 >97.0%(HPLC)(T)
Ethyl 3-Carbamimidoylamino-4-methylbenzoate Nitrate
>97.0%(HPLC)(T) |
641569-96-2 |
5g |
￥43200 |
2024-03-01 |
購入 |
3-カルバムイミドイルアミノ-4-メチル安息香酸エチル硝酸塩 化学特性,用途語,生産方法
外観
白色～ほとんど白色粉末～結晶
化学的特性
3-[(Aminoiminomethyl)amino]-4-methylbenzoic acid ethyl ester mononitrate Appearance white to almost white powder to crystals, melting point 199 °C, storage 2-8 °C.
使用
3-[(Aminoiminomethyl)amino]-4-methylbenzoic acid ethyl ester mononitrate is an organic synthetic material or pharmaceutical intermediate compound that can be used in the preparation of N-phenyl-2-pyrimidinamine derivatives and in the synthesis of nilotinib and its salts. Nilotinib is a tyrosine kinase inhibitor used for the treatment of drug-resistant chronic myelogenous leukemia (CML), and in particular, for the treatment of chronic phase and accelerated phase Philadelphia chromosome positive chronic myeloid leukemia (CML) in adult patients whose disease has progressed on or who cannot tolerate other therapies that included imatinib. Nilotinib is administrated as a hydrochloride salt in the form of capsules that are marketed in the USA and the EU under the name Tasigna?.
3-カルバムイミドイルアミノ-4-メチル安息香酸エチル硝酸塩 上流と下流の製品情報
原材料
準備製品
3-カルバムイミドイルアミノ-4-メチル安息香酸エチル硝酸塩 生産企業
Global( 146)Suppliers
641569-96-2(3-カルバムイミドイルアミノ-4-メチル安息香酸エチル硝酸塩)キーワード:
- 641569-96-2
- 3-[(Aminoiminomethyl)amino]-4-methylbenzoic acid ethyl ester mononitrate
- 3-[(AMinoiMinoMethyl)aMino]-4-Methylbenzoic acid ethyl ester Mon
- Ethyl 3-guanidino-4-methylbenzoate nitrate
- Ethyl 3-Carbamimidoylamino-4-methylbenzoate Nitrate
- 3-[(Aminoimethyl)amino]-4-methylbenzoic acid ethyl estermononitrate
- ((aminoiminomethyl)amino)-4-methylbenzoic acid ethyl ester mononitrate
- ethyl 3-guanidino-4-methylbenzoate
- 3-(hydrazinylmethylideneamino)-4-methylbenzoic acid ethyl ester
- NILOTINIB IMPURITY 22
- Ethyl 3-Carbamimidoylamino-4-methylbenzoate Nitrate >
- Ethyl 3-Carbamimidoylamino-p-toluate Nitrate
- 3-Carbamimidoylamino-p-toluic Acid Ethyl Ester Nitrate
- 3-Carbamimidoylamino-4-methylbenzoic Acid Ethyl Ester Nitrate
- Nilotinib Impurity 35
- Nilotinib Impurity 16(Nitrate)
- 2-Methyl-5-(ethylcarboxy)phenylguanidine nitrate
- Benzoic acid, 3-[(aminoiminomethyl)amino]-4-methyl-, ethyl ester, nitrate (1:1)
- 3-[(aminoiminomethyl)amino]-4-methyl-Benzoic acid ethyl ester nitrate (1:1)
- 3-[(AMINOIMINOMETHYL)AMINO]-4-METHYL ENZOICACIDMETHYLESTERMONONITRATE
- 3-カルバムイミドイルアミノ-4-メチル安息香酸エチル硝酸塩
- 3-カルバムイミドイルアミノ-p-トルイル酸硝酸塩
- 3-[(アミノイミノメチル)アミノ]-4-メチル安息香酸エチル一硝酸エステル